Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
C5678 ST638Summary: tyrosine kinase inhibitor and PLD inhibitor
-
C5763 Cycloguanil (hydrochloride)Summary: inhibitor of dihydrofolate reductase (DHFR)
-
C5811 5,8,11-Eicosatriynoic AcidSummary: nonselective inhibitor of lipoxygenases (12-LO)
-
C5719 Oleyl Trifluoromethyl KetoneSummary: potent inhibitor of FAAH
-
C3458 N,N'-DicyclohexylureaSummary: soluble epoxide hydrolase (sEH) inhibitor
-
B5162 T 0156 hydrochlorideSummary: inhibitor of phosphodiesterase type 5 (PDE5)
-
B5354 CGP 3466B maleateTarget: GAPDHSummary: GAPDH inhibitor
-
B5402 TCS PrP Inhibitor 13Summary: Antiprion agent,inhibits protease-resistant prion protein (PrP-res) accumulation
-
B5405 YM 511Summary: aromatase (CYP19) inhibitor
-
B5448 CP 316819Summary: Selective glycogen phosphorylase inhibitor